EP 2744915 A1 20140625 - USE OF CCNE2 AS A STRATIFICATION MARKER IN THE TREATMENT OF BREAST TUMOURS WITH NOVEL PAN-CDK INHIBITORS
Title (en)
USE OF CCNE2 AS A STRATIFICATION MARKER IN THE TREATMENT OF BREAST TUMOURS WITH NOVEL PAN-CDK INHIBITORS
Title (de)
VERWENDUNG VON CCNE2 ALS STRATIFIKATIONSMARKER BEI DER BEHANDLUNG VON BRUSTTUMOREN MIT NEUEN PAN-CDK-INHIBITOREN
Title (fr)
UTILISATION DE CCNE2 COMME MARQUEUR DE STRATIFICATION DANS LE TRAITEMENT DE TUMEURS DU SEIN AVEC DE NOUVEAUX INHIBITEURS DE KINASES CYCLINE-DÉPENDANTES (CDK) PAN
Publication
Application
Priority
- DE 102011080991 A 20110816
- EP 2012065947 W 20120815
Abstract (en)
[origin: CA2845324A1] The invention relates to the use of CCNE2 as a stratification marker in the treatment of breast tumours with novel pan-CDK inhibitors of formula (I).
IPC 8 full level
C12Q 1/68 (2006.01)
CPC (source: CN EP US)
C12Q 1/6886 (2013.01 - CN EP US); G01N 33/57496 (2013.01 - US); C12Q 2600/158 (2013.01 - CN EP US)
Citation (search report)
See references of WO 2013024118A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
DE 102011080991 A1 20130221; AU 2012296839 A1 20140227; BR 112014003096 A2 20170221; CA 2845324 A1 20130221; CN 103732762 A 20140416; EA 201490411 A1 20140730; EP 2744915 A1 20140625; IL 230781 A0 20140331; JP 2014524250 A 20140922; KR 20140044911 A 20140415; MX 2014001810 A 20140331; US 2014221243 A1 20140807; WO 2013024118 A1 20130221
DOCDB simple family (application)
DE 102011080991 A 20110816; AU 2012296839 A 20120815; BR 112014003096 A 20120815; CA 2845324 A 20120815; CN 201280039711 A 20120815; EA 201490411 A 20120815; EP 12766598 A 20120815; EP 2012065947 W 20120815; IL 23078114 A 20140203; JP 2014525443 A 20120815; KR 20147003676 A 20120815; MX 2014001810 A 20120815; US 201214238748 A 20120815